ZYDUS LIFESCIENCES
Back to Balance Sheet
|
ZYDUS LIFESCIENCES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹34,858 Cr | ₹27,637 Cr | ₹24,494 Cr | ₹26,700 Cr | ₹22,810 Cr |
What is the latest Total Liabilities ratio of ZYDUS LIFESCIENCES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹34,858 Cr |
| Mar2024 | ₹27,637 Cr |
| Mar2023 | ₹24,494 Cr |
| Mar2022 | ₹26,700 Cr |
| Mar2021 | ₹22,810 Cr |
How is Total Liabilities of ZYDUS LIFESCIENCES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹34,858 Cr | 26.13 | |
| Mar2024 | ₹27,637 Cr | 12.83 | |
| Mar2023 | ₹24,494 Cr | -8.26 | |
| Mar2022 | ₹26,700 Cr | 17.05 | |
| Mar2021 | ₹22,810 Cr | - | |
Compare Total Liabilities of peers of ZYDUS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ZYDUS LIFESCIENCES | ₹88,424.9 Cr | -1.6% | -3.9% | -4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,341.0 Cr | -1.8% | -6.4% | -10.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,401.0 Cr | -0.3% | -5.5% | 8.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,175.0 Cr | -0.1% | 4% | 18.7% | Stock Analytics | |
| CIPLA | ₹107,100.0 Cr | 1% | -12.3% | -5.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,715.9 Cr | -4.6% | -7% | 1.8% | Stock Analytics | |
ZYDUS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ZYDUS LIFESCIENCES | -1.6% |
-3.9% |
-4% |
| SENSEX | -1% |
-4.7% |
6% |
You may also like the below Video Courses